Highly Rated, Highly Effective

Our programs are highly rated because we focus on each individual’s needs. Personalized treatment ensures patients feel cared for and empowered throughout their recovery.

How We Measure Success

Our comprehensive approach ensures that every patient’s journey is backed by measurable outcomes and long-term support. From improving quality of life to maintaining recovery, we track results to continuously refine our care and empower more people’s recovery.

PATIENT SATISFACTION

Exceptional Completion Rates


Our personalized care plans keep patients engaged in their recovery.

89% of Patients Complete Treatment

From the start, we focus on building trust and delivering care personalized to each individual. Our patient-centered approach fosters a supportive environment and strong community, leading to unmatched treatment completion rates.


Vista Research Group is dedicated to improving addiction and mental health treatment outcomes through the smart use of data. Founded by Joanna Conti, who was driven by her personal experience as a mother navigating her daughter’s addiction journey, Vista provides real-time patient monitoring tools to help clinicians identify and address challenges during treatment. Additionally, Vista conducts post-treatment follow-up research to measure success rates and benchmark effectiveness across different treatment programs.

About This Data

Patient Satisfaction

  • 2024 The Meadows Inpatient / Residential Program Data
    • 91% (2,332 surveys completed) of patients said they were very satisfied and somewhat satisfied with the treatment they received at The Meadows.
  • Completed Surveys Through Vista Research Group

Treatment Completion

  • 2024 The Meadows Inpatient / Residential Program Data
    • Of the 1,182 patients included in the survey, 89% completed treatment, transferred care following completion or were referred to a higher level of care for completion.
  • Completed Surveys Through Vista Research Group

Improved Well-Being

  • October 2022 – October 2024 All Meadows Programs (Inpatient & Outpatient) Discharges; *This data includes patients that were reachable post-treatment.
    • 1 Month Post-Treatment: Of the 1,026 patients who completed the one-month post-treatment survey, 91.7% reported feeling excellent, good, or fair.
    • 6 Month Post-Treatment: Of the 646 patients who completed the six-month post-treatment survey, 91.3% reported feeling excellent, good, or fair.
    • 12 Month Post-Treatment: Of the 324 patients who completed the one-year post-treatment survey, 91.9% reported feeling excellent, good, or fair.
  • Completed Surveys Through Vista Research Group

Found Therapy Helpful

  • 2024 The Meadows Combined Program (Inpatient and Outpatient) Data.
    • Of the 3,122 patients who completed the survey, 97% reported individual therapy as somewhat helpful, very helpful, and extremely helpful. 
    • Of the 3,344 patients who completed the survey, 94% reported group therapy as somewhat helpful, very helpful, or extremely helpful.
  • Completed Surveys Through Vista Research Group

Average Length of Stay

  • 2024 The Meadows Inpatient / Residential Program Data (AZ and CA only)
  • Completed Surveys Through Vista Research Group